| Breakdown | Oct 2025 | Oct 2024 | Oct 2023 | Oct 2022 | Oct 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 373.11B | 343.33B | 251.87B | 142.79B | 118.56B |
| Gross Profit | 117.97B | 110.62B | 82.74B | 28.26B | 16.38B |
| EBITDA | 20.68B | 22.37B | 11.95B | 6.95B | -36.42B |
| Net Income | 4.72B | 8.72B | -2.62B | -11.50B | -50.05B |
Balance Sheet | |||||
| Total Assets | 386.33B | 412.20B | 440.96B | 414.79B | 412.29B |
| Cash, Cash Equivalents and Short-Term Investments | 113.93B | 138.17B | 157.59B | 145.01B | 101.42B |
| Total Debt | 179.07B | 211.86B | 266.15B | 276.75B | 277.36B |
| Total Liabilities | 319.12B | 349.85B | 391.22B | 366.55B | 348.14B |
| Stockholders Equity | 55.84B | 52.25B | 40.75B | 39.59B | 40.78B |
Cash Flow | |||||
| Free Cash Flow | 14.06B | 21.05B | 24.59B | -23.83B | -44.96B |
| Operating Cash Flow | 21.22B | 29.25B | 31.07B | -14.91B | -28.40B |
| Investing Cash Flow | -11.14B | 45.61B | -46.39B | 53.52B | -7.09B |
| Financing Cash Flow | -36.33B | -55.16B | -11.79B | 5.46B | 40.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥15.55B | 59.29 | ― | ― | 14.37% | -44.67% | |
67 Neutral | ¥246.51B | 29.55 | ― | 1.51% | 11.92% | 33.70% | |
64 Neutral | ¥79.34B | 7.01 | 8.65% | 1.52% | 8.75% | -43.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥4.45T | 23.18 | 12.54% | 0.48% | 10.59% | 13.93% | |
53 Neutral | ¥113.40B | 32.53 | ― | ― | 62.69% | -37.72% | |
52 Neutral | ¥46.63B | 49.41 | ― | ― | 6.00% | -184.09% |